UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biologic and Systemic Agents in Dermatology

1st ed. 2018 edition., 2018

Volltextzugriff (PDF)

Management of scrotal pruritus with topical roflumilast 0.3% once daily treatment

JAAD Case Reports, 2024-05, Vol.47, p.4-5

Yamauchi, Paul S.

2024

Volltextzugriff (PDF)

IL-4 and IL-13 Inhibition in Atopic Dermatitis

Journal of drugs in dermatology, 2016-08, Vol.15 (8), p.925

2016

Volltextzugriff (PDF)

Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent

Journal of the American Academy of Dermatology, 2016-09, Vol.75 (3), p.612-618.e6

2016

Volltextzugriff (PDF)

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (11), p.1073

2022

Volltextzugriff (PDF)

Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study

Journal of the American Academy of Dermatology, 2024-07, Vol.91 (1), p.91-99

2024

Volltextzugriff (PDF)

A brief guide to pustular psoriasis for primary care providers

Postgraduate medicine, 2021-04, Vol.133 (3), p.330-344

2021

Volltextzugriff (PDF)

New Biologics and Oral Drugs in Treatment of Moderate to Severe Psoriasis

Journal of drugs in dermatology, 2022-08, Vol.21 (8), p.826-831

2022

Volltextzugriff (PDF)

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results

Journal of the American Academy of Dermatology, 2015-01, Vol.72 (1), p.115-122

2015

Volltextzugriff (PDF)

Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement

Journal of drugs in dermatology, 2020-08, Vol.19 (8), p.698-701

2020

Volltextzugriff (PDF)

Psoriasis: Embarking a dynamic shift in the skin microbiota

Journal of cosmetic dermatology, 2022-04, Vol.21 (4), p.1402-1406

2022

Volltextzugriff (PDF)

Antihistamines in Psoriasis

Journal of drugs in dermatology, 2021-08, Vol.20 (8), p.844-847

2021

Volltextzugriff (PDF)

Treatment of Scalp Psoriasis

Journal of drugs in dermatology, 2022-08, Vol.21 (8), p.833-837

2022

Volltextzugriff (PDF)

From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis

Journal of the American Academy of Dermatology, 2016-10, Vol.75 (4), p.798-805.e7

2016

Volltextzugriff (PDF)

Treatment of Nail Psoriasis

Journal of drugs in dermatology, 2022-02, Vol.21 (2), p.146-150

2022

Volltextzugriff (PDF)

Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments

Drugs & aging, 2017-08, Vol.34 (8), p.583-588

2017

Volltextzugriff (PDF)

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2023-06, Vol.159 (6), p.613

2023

Volltextzugriff (PDF)

Therapeutic application of machine learning in psoriasis: A Prisma systematic review

Journal of cosmetic dermatology, 2023-02, Vol.22 (2), p.378-382

2023

Volltextzugriff (PDF)

Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies

Journal of drugs in dermatology, 2018-08, Vol.17 (8), p.855

2018

Volltextzugriff (PDF)

Absence of Koebnerization Following Ablative and Nonablative Laser Therapy in Patients With Plaque Psoriasis

Dermatologic surgery, 2016-04, Vol.42 (4), p.521-525

2016

Volltextzugriff (PDF)

Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibition

Journal of drugs in dermatology, 2015-03, Vol.14 (3), p.244

2015

Volltextzugriff (PDF)

Rapidly growing squamous cell carcinoma from permanent makeup tattoo

Journal of the American Academy of Dermatology, 2009-06, Vol.60 (6), p.1073-1074

2009

Volltextzugriff (PDF)

Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review

Dermatologic therapy, 2020-07, Vol.33 (4), p.e13800-n/a

2020

Volltextzugriff (PDF)

OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis

Journal of the American Academy of Dermatology, 2013-05, Vol.68 (5), p.756-764

2013

Volltextzugriff (PDF)

Emerging permanent filler technologies: focus on Aquamid

Clinical, cosmetic and investigational dermatology, 2014-01, Vol.7 (default), p.261-266

Yamauchi, Paul S

2014

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(263)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Biologic and Systemic Agents in Dermatology

Management of scrotal pruritus with topical roflumilast 0.3% once daily treatment

IL-4 and IL-13 Inhibition in Atopic Dermatitis

Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials

Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study

A brief guide to pustular psoriasis for primary care providers

New Biologics and Oral Drugs in Treatment of Moderate to Severe Psoriasis

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results

Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement

Psoriasis: Embarking a dynamic shift in the skin microbiota

Antihistamines in Psoriasis

Treatment of Scalp Psoriasis

From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis

Treatment of Nail Psoriasis

Managing Mild-to-Moderate Psoriasis in Elderly Patients: Role of Topical Treatments

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

Therapeutic application of machine learning in psoriasis: A Prisma systematic review

Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies

Absence of Koebnerization Following Ablative and Nonablative Laser Therapy in Patients With Plaque Psoriasis

Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibition

Rapidly growing squamous cell carcinoma from permanent makeup tattoo

Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review

OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis

Emerging permanent filler technologies: focus on Aquamid

Suchergebnisse filtern